Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

National Institute of Environmental Health Sciences

Use this QR code to view the newest version of this document
Use this QR code to view the newest version of this document

Your Environment. Your Health.

Publication Detail

Title: Structure-Guided Design of an Anti-dengue Antibody Directed to a Non-immunodominant Epitope.

Authors: Robinson, Luke N; Tharakaraman, Kannan; Rowley, Kirk J; Costa, Vivian V; Chan, Kuan Rong; Wong, Yee Hwa; Ong, Li Ching; Tan, Hwee Cheng; Koch, Tyree; Cain, David; Kirloskar, Rama; Viswanathan, Karthik; Liew, Chong Wai; Tissire, Hamid; Ramakrishnan, Boopathy; Myette, James R; Babcock, Gregory J; Sasisekharan, V; Alonso, Sylvie; Chen, Jianzhu; Lescar, Julien; Shriver, Zachary; Ooi, Eng Eong; Sasisekharan, Ram

Published In Cell, (2015 Jul 30)

Abstract: Dengue is the most common vector-borne viral disease, causing nearly 400 million infections yearly. Currently there are no approved therapies. Antibody epitopes that elicit weak humoral responses may not be accessible by conventional B cell panning methods. To demonstrate an alternative strategy to generating a therapeutic antibody, we employed a non-immunodominant, but functionally relevant, epitope in domain III of the E protein, and engineered by structure-guided methods an antibody directed to it. The resulting antibody, Ab513, exhibits high-affinity binding to, and broadly neutralizes, multiple genotypes within all four serotypes. To assess therapeutic relevance of Ab513, activity against important human clinical features of dengue was investigated. Ab513 mitigates thrombocytopenia in a humanized mouse model, resolves vascular leakage, reduces viremia to nearly undetectable levels, and protects mice in a maternal transfer model of lethal antibody-mediated enhancement. The results demonstrate that Ab513 may reduce the public health burden from dengue.

PubMed ID: 26189681 Exiting the NIEHS site

MeSH Terms: Amino Acid Sequence; Animals; Antibodies, Neutralizing/administration & dosage*; Antibodies, Neutralizing/chemistry*; Dengue Virus/immunology; Dengue Virus/physiology*; Dengue/immunology; Dengue/therapy*; Dengue/virology; Disease Models, Animal; Immunodominant Epitopes/chemistry*; Mice; Models, Molecular; Molecular Sequence Data; Phagocytosis; Protein Engineering; Receptors, Fc/immunology; Sequence Alignment

Back
to Top